Search Results
Anselm K. Gitt, MD: DYSIS and Increased Persistent Lipid Abnormalities
Are We Ever Going to Get to Lipid Goals?
Lipid Management for Secondary Prevention in Europe
Aktuelle Lipidtherapie & Zielwert-Erreichung in Deutschland bei Hochrisikopatient*innen
Congress by Day - Sunday 28 August 2016
Poushali Mukherjea from Bristol-Myers Squibb: Measures of Healthcare Delivery Are Important
Prof. Eberhard Standl (Germany)
Dr. Antonio Ceriello (Spain)
